European Cystic Fibrosis Society (ECFS)
Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > A letter in response to the recently published article entitled “Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis

A letter in response to the recently published article entitled “Effect of elexacaftor/tezacaftor/ivacaftor on annual rate of lung function decline in people with cystic fibrosis

Resource Type

CF Research News

Authors

Zhe Hui Hoo, Lana Yh Lai, Robert D Sandler, Tracey E Daniels, Sophie Dawson, Marlene Hutchings, Martin J Wildman

References

J Cyst Fibros. 2023 Mar 20;S1569-1993(23)00076-0. doi: 10.1016/j.jcf.2023.03.012.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Theme

Pulmonology [3]

Date

Monday, March 20, 2023

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [4]
Terms & Conditions Privacy policy  Accessibility Sitemap Contact 
© EUROPEAN CYSTIC FIBROSIS SOCIETY 2025. All rights reserved. Website by VidaVia (link is external)
European Cystic Fibrosis Society (ECFS)

Source URL:https://www.ecfs.eu/resource-article/cf-research-news/letter-response-recently-published-article-entitled-%E2%80%9Ceffect

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-22-00050R1_FINAL_HuiHoo_200423.pdf [2] https://pubmed.ncbi.nlm.nih.gov/36948912/ [3] https://www.ecfs.eu/research-article-themes/pulmonology [4] https://www.ecfs.eu/resource-guideline-type/other-guidelines